KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$25.5 million.

  • Cme's Change in Receivables fell 18585.86% to -$25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 8036.21%. This contributed to the annual value of $39.4 million for FY2024, which is 2349.51% down from last year.
  • Per Cme's latest filing, its Change in Receivables stood at -$25.5 million for Q3 2025, which was down 18585.86% from -$101.4 million recorded in Q2 2025.
  • Cme's 5-year Change in Receivables high stood at $241.2 million for Q1 2023, and its period low was -$125.5 million during Q2 2023.
  • Its 5-year average for Change in Receivables is $13.6 million, with a median of -$25.5 million in 2025.
  • As far as peak fluctuations go, Cme's Change in Receivables plummeted by 670000.0% in 2023, and later soared by 17279.41% in 2024.
  • Quarter analysis of 5 years shows Cme's Change in Receivables stood at -$36.1 million in 2021, then plummeted by 166.76% to -$96.3 million in 2022, then soared by 75.7% to -$23.4 million in 2023, then crashed by 138.46% to -$55.8 million in 2024, then skyrocketed by 54.3% to -$25.5 million in 2025.
  • Its Change in Receivables stands at -$25.5 million for Q3 2025, versus -$101.4 million for Q2 2025 and $196.8 million for Q1 2025.